Anti-LY75 / CD205 (CDX-1401) (A2602-GRP)

Anti-LY75 / CD205 (CDX-1401) human monoclonal antibodies targeting specific for CD205 (DEC-205). It is used to enhance anticancer immunity by exploiting the capacity of dendritic cells (DCs). MW :150 KD.